A comparative investigation of FK506 and cyclosporin A in murine corneal transplantation

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 236, Issue 10, 1998, Pages 785-789

  Reis, Alexander ^a   Reinhard, Thomas ^a   Sundmacher, Rainer ^a   Braunstein, Stefan ^a   Godehardt, Erhard ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; TACROLIMUS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORNEA TRANSPLANTATION; GRAFT SURVIVAL; HISTOLOGY; IMMUNOHISTOLOGY; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; RAT; SLIT LAMP;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CORNEA; CORNEAL TRANSPLANTATION; CYCLOSPORINE; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE AGENTS; POSTOPERATIVE PERIOD; RATS; RATS, INBRED BN; RATS, INBRED LEW; TACROLIMUS; TIME FACTORS; TRANSPLANTATION, ISOGENEIC;

EID: 0031717448     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004170050159     Document Type: Article

References (21)

1. Almond PS, Matas A, Gillingham K et al (1993) Risk factors for chronic rejection in renal allograft recipients. Transplantation 55:725-757
2. Bussutil RW, Holt CD (1997) Tacrolimus (FK506) is superior to cyclosporine in liver transplantation. Transplant Proc 29:534-438
3. Celli S, Valdivia J, Fung J et al (1993) Long-term survival of heart and liver xenografts with splenectomy and FK506. Transplant Proc 25:647f
4. Cummings CE (1992) Corneal graft statistics. Eye Bank Association of America, Washington DC
5. Herbort CR Matsubara M, Mishi M, Mochizuki M (1989) Penetrating keratoplasty in the rat: a model for the study of immunosuppressive treatment of graft rejection. Jpn J Ophthalmol 33:212-220
6. Hikita N, Lopez JS, Chan C, Mochizuki M et al (1997) Use of topical FK506 in a corneal graft rejection model in Lewis rats. Invest Ophthalmol Vis Sci 38:901-909
7. Hooks M (1994) Tacrolimus, a new immunosuppressant - a review of the literature. Ann Pharmacother 28:501-511
8. Kino T, Hatayama H, Hashimoto M et al (1987) FK506, a novel immunosuppressant isolated from Streptomyces. 1. Fermentation, isolation, and physicochemical and biological characteristics. J Antibiot 40:1249-1255
9. Nishi M, Herbort C, Matsubara M, Morishita Y, Nishimura M, Nieda M, Mori S, Mochizuki M (1993) Effects of the immunosuppressant FK506 on a penetrating keratoplasty rejection model in the rat. Invest Ophthalmol Vis Sci 34:2477-2486
10. Margreiter R (1996) Tacrolimus bei therapieresistenter Abstoßung nach Nierentransplantation. Pabst Science Publishers D-49525 Lengerich
11. Pichlmayr R, Bismuth H, Calne R et al (1996) Three-year data from the European multicentre tacrolimus liver study. XVI International Congress of the Transplantation Society, Barcelona, Spain, 25-30 August, abstract 307
12. Minamoto A, Sakata H, Okada K, Fujihara M (1995) Suppression of corneal graft rejection by subconjunctival injection of FK-506 in a rat model of penetrating keratoplasty. Jpn J Ophthalmol 39:12-19
13. Reinhard T, Kallman C, Cepin A, Godehardt E, Sundmacher R (1997) The influence of glaucoma on graft survival after penetrating keratoplasty. Graefe's Arch Clin Exp Ophthalmol 235:553-557
14. Reinhard T, Sundmacher R, Godehardt E (1997) Systemische Cyclosporin A Prophylaxe nach Keratoplastiken mit erhöhtem Risiko einer Immunreaktion als einzigem erhöhten Risikofaktor. Ophthalmologe 94:001-000
15. Sawada S, Suzuki G, Kawase Y, Takaku F (1987) Novel immunosuppresstive agent, FK506: in vitro effects on the cloned T cell activation. J Immunol 40:1249-1255
16. Starzl T (1993) Allograft and xenograft acceptance under FK506 and other immunosuppressant treatment. Ann NY Acad Sci 685:6-51
17. Sundmacher R (1997) Immunreaktionen nach Keratoplastik. Klin Monatsbl Augenheilkd 171:705-722
18. Sundmacher R, Stefansson A, Mackensen G (1983) Verlaufsbeobachtungen nach Keratoplastik. Fortschr Ophthalmol 80:224-227
19. Tanaka H, Kuroda A, Marusawa H et al (1987) Physiochemical properties of FK506, a novel immunosuppressant isolated from Streptomyces tsukubaensis. Transplant Proc [Suppl] 19:11-16
20. Woodle ES, Thistlethwaite JR, Gordon JH for the FK506 Kidney Transplant Rescue Study Group (1996) A multicenter trial of FK506 (tacrolimus) therapy in refractory acute renal allograft rejection. Transplantation 62:594-599
21. Yoshimura N, Matsui S, Hamashima T, Oka T (1989) Effects of a new immunosuppressive agent, FK506, on human lymphocyte responsiveness in vitro. I. Inhibition of expression of alloantigen-activated suppressor cells, as well as induction of alloreactivity. Transplantation 47:351-356